MeCure Industries Plc posted a profit after tax of N4.46 billion for the nine months ended September 30, a 186 percent rise from N1.56 billion in the same period of 2024, as revenue nearly doubled on strong domestic demand across its pharmaceutical and diagnostics divisions. The drug maker’s un
```
Members Only

Login or create an account to continue

This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.

New to BusinessDay? Register now and start reading.

```

Join BusinessDay whatsapp Channel, to stay up to date

Open In Whatsapp